跳至主要内容
临床试验/NL-OMON51262
NL-OMON51262已完成4 期

Timing and sequence of vaccination against COVID-19 and Influenza - TACTIC

Radboud Universitair Medisch Centrum0 个研究点目标入组 160 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Age equal to or above 60 years
  • Received a COVID-19 vaccine 4-12 months prior to enrollment

排除标准

  • History of COVID-19 infection (confirmed by a microbiological test)
  • Vaccination against influenza <6months
  • Immunocompromised (either by co-morbidities or induced by medication)
  • Known allergy or history of anaphylaxis or other serious adverse reactions to
  • Acute illness < 2 weeks
  • Participation in another drug trial

研究者

相似试验